Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study

European Journal of Gynaecological Oncology

Volumn 22, Issue 4, 2001, Pages 287-291

  Recchia, F ^a   De Filippis, S ^a   Rosselli, M ^a   Saggio, G ^a   Carta, G ^a   Rea, S ^a  

^a NONE   (Italy)

Author keywords

Carboplatin; Cyclophosphamide; Epirubicin; Paclitaxel; Primary chemotherapy; Stage IV ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; PACLITAXEL;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NAUSEA; NEUROLOGIC DISEASE; OVARY CARCINOMA; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PERIOD; TREATMENT PLANNING; TUMOR CELL; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYSTADENOCARCINOMA; DISEASE PROGRESSION; EPIRUBICIN; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034775999     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Long term survival in ovarian cancer
2. Epighelial ovarian carcinoma
3. Resistance to alkylating agents and cisplatin: Insight from ovarian carcinoma model systems
4. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis
5. Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials
6. Phase II trial of epirubicin at standard dose in relapsed ovarian cancer
7. Cyctophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
8. Cisplatin/paclitaxel vs carboplatin/paclitaxel as 1st line treatment in ovarian cancer
9. Primary chemotherapy for early and advanced breast cancer
10. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
11. Adjuvant and neoadjuvant treatment of head and neck cancers
12. Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
13. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
14. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
15. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
16. Reporting results of cancer treatment
17. Nonparametric estimation from incomplete observations
18. Secondary surgical cytoreduction for advanced epithelial ovarian cancer
19. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
20. Assessment of morbidity in primary cytoreductive surgery for advanced ovarian cancer
21. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
22. Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis?
23. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer
24. Treatment of stage III and IV ovarian cancer-is neoadjuvant chemotherapy effective?
25. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer